Navigation Links
Celsion Reports Third Quarter 2010 Financial Results and Provides Business Update
Date:11/15/2010

to Treat Primary Liver Cancer from the FDA;
  • NCI Consensus published in Journal of Clinical Oncology recommended the Phase III HEAT study as a Priority Clinical Trial for HCC;  
  • Positive FDA guidance relating to 505(b)(2) regulatory submission received for the Company's New Drug Application for ThermoDox® to Treat Primary Liver Cancer;
  • ThermoDox® clinical data presented at the 2010 Breast Cancer Symposium;
  • SBIR grant received to expand technology platform; and
  • Celsion presented at two Healthcare Conferences in New York City.

  • The Company is holding a conference call to provide a business update and discuss the third quarter 2010 results at 3:00 p.m. Eastern Time on November 15, 2010. To participate in the call, interested parties may dial 1-888-218-8172 (Toll free U.S./Canada) or 1-913-312-9313 (Toll/International) and use Conference ID: 4428936 to register ten minutes before the call is scheduled to begin. The call will also be broadcast live on the Internet at http://www.celsion.com.The call will be archived for replay on Monday, November 15, 2010 at 6:00 p.m. Eastern Time and will remain available until Monday, November 22, 2010. The replay can be accessed at 1-877-870-5176 (Toll free U.S./Canada) or 1-858-384-5517 (Toll/International) using Replay Pin: 4428936. An audio replay of the call will also be available on the Company's website, http://www.celsion.com, for 30 days after 5:00 p.m. Eastern Time on November 15, 2010.

    About ThermoDox®ThermoDox® in combination with hyperthermia has the potentia
    '/>"/>

    SOURCE Celsion Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. Celsion Announces Date and Time Change for Third Quarter 2010 Financial Results Conference Call to Monday, November 15, 2010
    2. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
    3. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
    4. Par Pharmaceutical Reports Second Quarter 2008 Results
    5. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
    6. Pharmos Corporation Reports 2008 Second Quarter Results
    7. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
    8. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
    9. BMP Sunstone Reports Second Quarter 2008 Financial Results
    10. ULURU Inc. Reports Second Quarter 2008 Financial Results
    11. Immtech Reports Fiscal First Quarter 2009 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/3/2015)... 03, 2015 Becht Engineering Co., ... it has acquired The CECON Group, Inc., located ... were not announced. , Becht Engineering (http://www.becht.com ... sector including oil and gas production, refining, petrochemical, ... nuclear power sectors. The company has twelve offices ...
    (Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/s3s3t8/personalized ... new report "Personalized Medicine - Scientific and ... The aim of personalized medicine or ... to the right patient and, in some cases, ... patient according to his/her genotype. This report describes ...
    (Date:3/3/2015)... 2015  Johnson & Johnson Innovation LLC today announced ... (JLABS @SSF), a 30,000-square foot incubator located ... Francisco, Calif. The Johnson & Johnson Innovation, ... from across the healthcare spectrum including biotech, pharmaceutical, medical ... first resident startups have been selected, including the winners ...
    (Date:3/3/2015)... , March 3, 2015  Synthetic Biologics, Inc. (NYSE ... and diseases, with a focus on protecting the microbiome, announced ... scheduled to present at the 27th Annual ROTH Conference being ... Laguna Niguel in Dana Point, CA. ... March 10, 2015 at 1:00 p.m. (Pacific Time). ...
    Breaking Biology Technology:Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 2Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 2Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 3Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 4Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups 5Synthetic Biologics to Present at the 27th Annual ROTH Conference 2
    ... Arena Pharmaceuticals, Inc.,(Nasdaq: ARNA ) announced today that ... Second Annual Hidden Gems Conference on October,13, 2008 at ... the,Waldorf=Astoria Hotel in New York City. Robert E. Hoffman, ... to provide an,overview of the company, including its clinical ...
    ... 7 Nektar,Therapeutics (Nasdaq: NKTR ) President and ... upcoming Natixis Bleichroeder Second Annual Hidden Gems,Conference in New ... at 2:30 p.m. ET., The presentation will be ... Relations, Events Calendar section of the Nektar website:, http://www.nektar.com ...
    ... 7 MKS Instruments, Inc.,(Nasdaq: MKSI ), ... and improve productivity, today announced that it will ... opening on Wednesday,October 22, 2008. A conference call ... 8:30 a.m. (Eastern Time). The call will be ...
    Cached Biology Technology:Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference 2Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference 3
    (Date:2/18/2015)... Feb. 18, 2015  Cepheid (NASDAQ: CPHD ) ... following conferences, and invited investors to participate via webcast. ... MA Tuesday, March 3, 2015 at 11.20 a.m. ... Orlando, FL Wednesday, March 4, 2015 at ... access the live webcasts for these events, please visit Cepheid,s ...
    (Date:2/12/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... for DISTRIBUTED METHOD AND SYSTEM TO IMPROVE ... further establishes NXT-ID,s position in the emerging "Internet of ... ability for multiple devices to collaborate with one another ...
    (Date:2/9/2015)... Texas , Feb. 9, 2015  Lintec of ... fabrication methods for carbon nanotube (CNT) macrostructures, including sheets, ... at Dallas (UTD). Leveraging the vast industrial ... Tokyo, Japan , Lintec of America is ... Richardson, TX , focusing on scaling up ...
    Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
    ... researchers from the British Antarctic Survey have collected individuals from ... and subjected them to increasing levels of water temperature to ... conditions that they are likely to experience in the future. ... living really close to their upper temperature range, and that ...
    ... A University of Wisconsin-Madison biomedical engineer and colleagues have developed ... could spare some women with increased breast cancer risk the ... a questionable lump or lesion. The universal technology will ... malignant or benign. The American Cancer Society recommends ...
    ... an effort to increase understanding of the medical device ... of product development more effectively, researchers at Stanford University ... device development process. Published in the June ... , the model was constructed based on best-practice analysis ...
    Cached Biology News:New MRI technique could mean fewer breast biopsies in high-risk women 2Stanford researchers publish comprehensive model for medical device development 2Stanford researchers publish comprehensive model for medical device development 3
    Phospho-TAO2 (S181) Affinity Purified Polyclonal Ab Protein Family: Other Intracellular Kinases...
    PEG 8000, Molecular Biology Grade...
    ... Histone Deacetylase (HDAC) Antibody Sampler Kit ... (HDAC1) Antibody, Catalog #2062, 40 ul Histone ... ul Histone Deacetylase 4 (HDAC4) Antibody, Catalog ... Antibody, Catalog #2082, 40 ul Histone Deacetylase ...
    Immunogen: Synthetic Peptide: C N(185) D G T E F G G S I Y Q K(197) Storage: -20 C, Avoid Freeze/Thaw Cycles...
    Biology Products: